Prakt. lékáren. 2014; 10(5): 165

Komentář ke článku „Nová protidestičková léčiva - prasugrel, tikagrelor, kangrelor“

prof. PharmDr. Martin Doležal, Ph.D.
Katedra farmaceutické chemie a kontroly léčiv,
Farmaceutická fakulta v Hradci Králové,
Univerzita Karlova v Praze

Published: October 24, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Doležal M. Komentář ke článku „Nová protidestičková léčiva - prasugrel, tikagrelor, kangrelor“. Praktické lékárenství. 2014;10(5):165.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Hagihara K, Kazui M, Kurihara A, a kol. Biotransformation of Prasugrel, a Novel Thienopyridine Antiplatelet Agent, to the Pharmacologically Active Metabolite. Drug Met. Dispos. 2010; 38: 898-904. Go to original source... Go to PubMed...
    2. Doležal M. Komentář - prasugrel. Prakt. Lékárenství 2010; 6: 172.
    3. The Merck Index, 15th Edition, 2013 by Merck & Co., Inc., Whitehouse Station, ISBN 0-978-1-84973-670-1, NJ, USA.
    4. Ingall AH, Cage PA, Kindon ND. (Astra Pharma Prod) N-Alkyl-2-substituted ATP analogues. WO 9418216 (1994).

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.